SCHEMBL19082046

SCHEMBL19082046

c1ccc2c(-c3c4ccccc4c(-c4ccc(-c5c6oc7ccccc7c6cc6c5sc5ccc7ccccc7c56)c5ccccc45)c4ccccc34)cccc2c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 2/20 0.38
TDP1 Q9NUW8 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
ESR1 P03372 1/20 0.32
ESR2 Q92731 1/20 0.32
AHR P35869 3/20 0.32
MAPT P10636 2/20 0.31
CYP2C9 P11712 2/20 0.31
CYP2C19 P33261 2/20 0.31
MEN1 O00255 1/20 0.31
TP53 P04637 1/20 0.31
CYP3A4 P08684 1/20 0.31
CYP2D6 P10635 1/20 0.31
KMT2A Q03164 1/20 0.31
NQO1 P15559 1/20 0.31
NQO2 P16083 1/20 0.31
KDM4E B2RXH2 1/20 0.30
ALDH1A1 P00352 1/20 0.30
GAA P10253 1/20 0.30
HPGD P15428 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19081956 0.92 ALOX5 (0.33) ALOX5TDP1L3MBTL1AHRCYP1A2
SCHEMBL19081865 0.88 ABCG2 (0.34) ALOX5TDP1L3MBTL1ESR1ESR2
SCHEMBL19082045 0.86 ALOX5 (0.38) ALOX5TDP1L3MBTL1ESR1ESR2
SCHEMBL19081806 0.85 TDP1 (0.36) ALOX5TDP1L3MBTL1ESR1ESR2
SCHEMBL19081791 0.83 TDP1 (0.36) TDP1L3MBTL1ESR1ESR2AHR
SCHEMBL19081653 0.82 ALOX5 (0.41) ALOX5TDP1L3MBTL1AHRMAPT
SCHEMBL17944165 0.82 ALOX5 (0.47) ALOX5ESR1ESR2AHRMAPT
SCHEMBL19081974 0.81 NPC1 (0.34) ALOX5TDP1L3MBTL1ESR1ESR2
SCHEMBL19081814 0.81 NPC1 (0.34) ALOX5TDP1L3MBTL1ESR1ESR2
SCHEMBL19082365 0.81 NQO2 (0.37) ALOX5L3MBTL1MAPTNQO1NQO2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-02-04 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNT1 ALOX5 1939/4885TDP1 2322/4885L3MBTL1 1245/4885
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 ALOX5 1939/4885TDP1 2322/4885L3MBTL1 1245/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.